Rhenman & Partners Asset Management Ab 13F annual report
Rhenman & Partners Asset Management Ab is an investment fund managing more than $1.04 trillion ran by Teresa Isele. There are currently 93 companies in Mrs. Isele’s portfolio. The largest investments include United Health Group Inc and Elevance Health Inc, together worth $100 billion.
$1.04 trillion Assets Under Management (AUM)
As of 6th August 2024, Rhenman & Partners Asset Management Ab’s top holding is 105,300 shares of United Health Group Inc currently worth over $53.6 billion and making up 5.1% of the portfolio value.
In addition, the fund holds 85,800 shares of Elevance Health Inc worth $46.5 billion.
The third-largest holding is Boston Scientific worth $45.8 billion and the next is Lilly Eli & Co worth $42.6 billion, with 47,000 shares owned.
Currently, Rhenman & Partners Asset Management Ab's portfolio is worth at least $1.04 trillion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
Careers at Rhenman & Partners Asset Management Ab
The Rhenman & Partners Asset Management Ab office and employees reside in Stockholm, Sweden. According to the last 13-F report filed with the SEC, Teresa Isele serves as the CEO at Rhenman & Partners Asset Management Ab.
Recent trades
In the most recent 13F filing, Rhenman & Partners Asset Management Ab revealed that it had opened a new position in
Edwards Lifesciences Corp and bought 97,500 shares worth $9.01 billion.
This means they effectively own approximately 0.1% of the company.
Edwards Lifesciences Corp makes up
1.2%
of the fund's Health Care sector allocation and has decreased its share price by approximately 0.1% in the past year.
The investment fund also strengthened its position in United Health Group Inc by buying
64,800 additional shares.
This makes their stake in United Health Group Inc total 105,300 shares worth $53.6 billion.
On the other hand, there are companies that Rhenman & Partners Asset Management Ab is getting rid of from its portfolio.
Rhenman & Partners Asset Management Ab closed its position in Shockwave Medical on 13th August 2024.
It sold the previously owned 64,000 shares for $20.8 billion.
Teresa Isele also disclosed a decreased stake in Lilly Eli & Co by 0.1%.
This leaves the value of the investment at $42.6 billion and 47,000 shares.
One of the average hedge funds
The two most similar investment funds to Rhenman & Partners Asset Management Ab are American Express Co and First Long Island Investors. They manage $1.04 trillion and $1.04 trillion respectively.
Teresa Isele investment strategy
Rhenman & Partners Asset Management Ab’s portfolio is diversified across 4 sectors.
Currently, their heaviest sector is Health Care — making up 73.3% of
the total portfolio value.
The fund focuses on investments in the United States as
73.1% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are large-cap stocks.
Stocks with a size of more than $10 billion in market cap make up
32% of the total holdings value.
On the other hand, small-cap stocks make up only approximately 0.1% of the portfolio.
The average market cap of the portfolio companies is close to $34.5 billion.
The complete list of Rhenman & Partners Asset Management Ab trades based on 13F SEC filings
These positions were updated on August 13th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| United Health Group Inc |
160.00%
105,300
|
$53,625,078,000 | 5.15% |
| Elevance Health Inc |
23.45%
85,800
|
$46,491,588,000 | 4.46% |
| Boston Scientific Corp. |
2.23%
595,000
|
$45,820,950,000 | 4.40% |
| Lilly Eli & Co |
13.24%
47,000
|
$42,552,860,000 | 4.09% |
| Regeneron Pharmaceuticals, Inc. |
6.71%
32,000
|
$33,632,960,000 | 3.23% |
| Abbvie Inc |
0.26%
189,000
|
$32,417,280,000 | 3.11% |
| Tenet Healthcare Corp. |
39.74%
229,000
|
$30,463,870,000 | 2.92% |
| Oscar Health, Inc. |
12.72%
1,906,611
|
$30,162,586,000 | 2.90% |
| Cooper Cos Inc |
2.99%
310,000
|
$27,063,000,000 | 2.60% |
| Intuitive Surgical Inc |
19.80%
60,500
|
$26,913,425,000 | 2.58% |
| Procept Biorobotics Corp |
9.66%
440,000
|
$26,879,600,000 | 2.58% |
| Becton Dickinson & Co. |
2.59%
113,000
|
$26,409,230,000 | 2.54% |
| HCA Healthcare Inc |
18.00%
82,000
|
$26,344,960,000 | 2.53% |
| Vertex Pharmaceuticals, Inc. |
4.42%
54,000
|
$25,310,880,000 | 2.43% |
| Cigna Group (The) |
45.93%
74,171
|
$24,518,707,000 | 2.35% |
| Merck & Co Inc |
19.91%
175,000
|
$21,665,000,000 | 2.08% |
| Shockwave Medical Inc. |
Closed
64,000
|
$20,840,320,000 | |
| Alnylam Pharmaceuticals Inc |
102.13%
85,500
|
$20,776,500,000 | 1.99% |
| Biomarin Pharmaceutical Inc. |
5.89%
251,500
|
$20,705,995,000 | 1.99% |
| Biogen Inc |
49.30%
84,800
|
$19,658,336,000 | 1.89% |
| Mckesson Corporation |
31.82%
30,000
|
$17,521,200,000 | 1.68% |
| Natera Inc |
34.58%
157,000
|
$17,001,530,000 | 1.63% |
| Medtronic Plc |
36.00%
208,000
|
$16,371,680,000 | 1.57% |
| Gilead Sciences, Inc. |
87.80%
238,500
|
$16,363,485,000 | 1.57% |
| Abbott Labs |
21.62%
145,000
|
$15,066,950,000 | 1.45% |
| Royalty Pharma plc |
No change
544,697
|
$14,363,660,000 | 1.38% |
| Dynavax Technologies Corp. |
6.48%
1,232,361
|
$13,839,414,000 | 1.33% |
| Align Technology, Inc. |
13.00%
56,500
|
$13,640,795,000 | 1.31% |
| Thermo Fisher Scientific Inc. |
84.62%
24,000
|
$13,272,000,000 | 1.27% |
| Dexcom Inc |
15.52%
117,000
|
$13,265,460,000 | 1.27% |
| Centene Corp. |
53.86%
198,482
|
$13,159,357,000 | 1.26% |
| Alignment Healthcare Inc |
18.85%
1,641,448
|
$12,836,123,000 | 1.23% |
| Jazz Pharmaceuticals plc |
22.31%
114,000
|
$12,167,220,000 | 1.17% |
| Danaher Corp. |
340.91%
48,500
|
$12,117,725,000 | 1.16% |
| Cencora Inc. |
21.18%
51,500
|
$11,602,950,000 | 1.11% |
| Cytokinetics Inc |
No change
197,515
|
$10,701,363,000 | 1.03% |
| Neurocrine Biosciences, Inc. |
28.06%
75,555
|
$10,401,657,000 | 1.00% |
| Axsome Therapeutics Inc |
11.14%
127,600
|
$10,271,800,000 | 0.99% |
| Intra-Cellular Therapies Inc |
3.27%
142,000
|
$9,725,580,000 | 0.93% |
| Insulet Corporation |
33.81%
46,500
|
$9,383,700,000 | 0.90% |
| Edwards Lifesciences Corp |
Opened
97,500
|
$9,006,075,000 | 0.86% |
| Zimmer Biomet Holdings Inc |
Closed
67,500
|
$8,908,650,000 | |
| NovoCure Ltd |
Closed
495,307
|
$7,741,648,000 | |
| Madrigal Pharmaceuticals Inc |
27.40%
26,500
|
$7,424,240,000 | 0.71% |
| Iovance Biotherapeutics Inc |
3.66%
920,000
|
$7,378,400,000 | 0.71% |
| Charles Riv Labs Intl Inc |
167.72%
34,000
|
$7,023,720,000 | 0.67% |
| Insmed Inc |
Opened
99,513
|
$6,667,371,000 | 0.64% |
| IQVIA Holdings Inc |
No change
31,000
|
$6,554,640,000 | 0.63% |
| Nuvalent Inc |
5.43%
82,750
|
$6,277,415,000 | 0.60% |
| Ionis Pharmaceuticals Inc |
Opened
130,000
|
$6,195,800,000 | 0.59% |
| Exact Sciences Corp. |
1.40%
145,000
|
$6,126,250,000 | 0.59% |
| Stryker Corp. |
125.00%
18,000
|
$6,124,500,000 | 0.59% |
| Arvinas Inc |
35.29%
230,000
|
$6,122,600,000 | 0.59% |
| Viking Therapeutics Inc |
20.69%
115,000
|
$6,096,150,000 | 0.59% |
| Glaukos Corporation |
85.19%
50,000
|
$5,917,500,000 | 0.57% |
| Merus N.V |
Opened
90,500
|
$5,354,885,000 | 0.51% |
| Encompass Health Corp |
106.90%
60,000
|
$5,147,400,000 | 0.49% |
| Syndax Pharmaceuticals Inc |
28.01%
228,500
|
$4,691,105,000 | 0.45% |
| BridgeBio Pharma Inc |
76.56%
184,500
|
$4,673,385,000 | 0.45% |
| Mirum Pharmaceuticals Inc |
45.53%
134,250
|
$4,590,008,000 | 0.44% |
| Janux Therapeutics Inc |
2.25%
106,847
|
$4,475,821,000 | 0.43% |
| Annexon Inc |
Opened
900,000
|
$4,410,000,000 | 0.42% |
| Esperion Therapeutics Inc Ne |
Opened
1,975,000
|
$4,384,500,000 | 0.42% |
| Essa Pharma Inc |
11.60%
806,054
|
$4,239,844,000 | 0.41% |
| Xencor Inc |
No change
218,750
|
$4,140,938,000 | 0.40% |
| Penumbra Inc |
50.00%
23,000
|
$4,139,310,000 | 0.40% |
| TG Therapeutics Inc |
72.87%
213,500
|
$3,798,165,000 | 0.36% |
| Nurix Therapeutics, Inc. |
Opened
174,393
|
$3,639,582,000 | 0.35% |
| Alkermes plc |
36.36%
150,000
|
$3,615,000,000 | 0.35% |
| Krystal Biotech Inc |
No change
19,000
|
$3,489,160,000 | 0.33% |
| Immunovant Inc |
3.98%
130,500
|
$3,445,200,000 | 0.33% |
| Kura Oncology In |
No change
166,526
|
$3,428,770,000 | 0.33% |
| Alpine Immune Sciences Inc |
Closed
85,500
|
$3,389,220,000 | |
| Staar Surgical Co Call |
Opened
65,000
|
$3,094,650,000 | 0.30% |
| Acadia Healthcare Company Inc |
215.46%
39,824
|
$2,689,713,000 | 0.26% |
| Inspire Med Sys Inc |
59.52%
17,000
|
$2,275,110,000 | 0.22% |
| Apellis Pharmaceuticals Inc |
68.95%
55,395
|
$2,124,952,000 | 0.20% |
| Molina Healthcare Inc |
Opened
7,000
|
$2,081,100,000 | 0.20% |
| TransMedics Group, Inc. |
Opened
13,500
|
$2,033,370,000 | 0.20% |
| Privia Health Group Inc |
No change
114,000
|
$1,981,320,000 | 0.19% |
| Immunocore Hldgs Plc |
26.95%
58,278
|
$1,975,041,000 | 0.19% |
| IDEAYA Biosciences, Inc. |
Opened
53,500
|
$1,878,385,000 | 0.18% |
| Revance Therapeutics Inc |
No change
701,707
|
$1,803,387,000 | 0.17% |
| INmune Bio, Inc. |
No change
178,284
|
$1,572,465,000 | 0.15% |
| Relay Therapeutics, Inc. |
No change
230,000
|
$1,499,600,000 | 0.14% |
| Bio-Techne Corp |
25.00%
20,000
|
$1,433,000,000 | 0.14% |
| Xenon Pharmaceuticals Inc |
Opened
35,000
|
$1,364,650,000 | 0.13% |
| IGM Biosciences, Inc. |
No change
195,000
|
$1,339,650,000 | 0.13% |
| AMGEN Inc. |
No change
4,250
|
$1,327,913,000 | 0.13% |
| Intellia Therapeutics Inc |
Closed
48,000
|
$1,320,480,000 | |
| Pliant Therapeutics, Inc. |
17.21%
120,250
|
$1,292,688,000 | 0.12% |
| Avantor, Inc. |
64.91%
60,000
|
$1,272,000,000 | 0.12% |
| Repligen Corp. |
100.00%
10,000
|
$1,260,600,000 | 0.12% |
| Medpace Holdings Inc |
Opened
2,500
|
$1,029,625,000 | 0.10% |
| Inari Med Inc |
64.55%
20,000
|
$963,000,000 | 0.09% |
| Evolent Health Inc |
Opened
50,000
|
$956,000,000 | 0.09% |
| Augmedix Inc |
25.00%
1,000,000
|
$880,000,000 | 0.08% |
| Bruker Corp |
70.00%
6,000
|
$382,860,000 | 0.04% |
| No transactions found | |||
| Showing first 500 out of 98 holdings | |||
Hedge funds similar to Rhenman & Partners Asset Management Ab
- Sax Wealth Advisors
- Howe & Rusling Inc
- Condor Capital Management
- True Link Advisors
- Kintegral Advisory
- Cardiff Park Advisors
- American Express Co
- First Long Island Investors
- Bdf-gestion
- Qvt L.P.
- Cape Cod Five Cents Savings Bank
- Capital Investment Services Of America
- Tritonpoint Wealth
- Trigran Investments